GLICLAGLAZE MR 30

Description

GLICLAGLAZE MR 30 gliclazide sr (30 mg) Gliclazide SR (Sustained Release) is a medication used primarily in the management of type 2 diabetes mellitus. It belongs to a class of drugs known as sulfonylureas, which work by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels. The “SR“ designation stands for sustained release, indicating that the medication is formulated to release the active ingredient gradually over time, providing a more controlled and prolonged effect compared to immediate-release formulations. This sustained release helps in maintaining more stable blood sugar levels throughout the day, reducing the risk of hypoglycemia (low blood sugar) and providing convenience by requiring fewer daily doses. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com / contact@sterispharma.com call/whatsapp: 8209542042, 8955945010, 6377716668 order now: https://www.sterisonline.com/product/gliclaglaze-mr-30-133422